Self-Affirmation and Response to Health Risk Information
Public ClinicalTrials.gov record NCT01668771. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Self-Affirmation, Affect, and Implementation Intentions for Alcohol Cessation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Background: \- Self-affirmation is the process of reflecting on values that a person considers important. This process may encourage people to be more open to information about health risks. It may also encourage them to change their behaviors or lifestyle to decrease these health risks. Researchers want to look at the effect of self-affirmation on people s responses to new health risk information. Because recent studies have linked alcohol consumption to increased risk of breast cancer, the study will focus on alcohol s link to breast cancer. Objectives: \- To study how self-affirmation can change opinions following a message about a health risk. Eligibility: \- Women at least 18 years of age who drink at least two alcoholic beverages per week and/or at least three alcoholic beverages per sitting. Design: * Participants will be recruited through an online panel. The study will be conducted entirely online. * Participants will respond to two short studies. The first will ask about life events and how they make people feel. The second will look at how people respond to information about alcohol and breast cancer. * For the first study, participants will write a paragraph or two about an important event in their lives. They will answer questions about how that event made them feel. They will also write a paragraph about an important personal value. * For the second study, participants will read information about alcohol and breast cancer risk. They will then answer questions about this information. They will also answer questions about their beliefs about alcohol and breast cancer. * Participants will receive financial compensation for being in this study.
Study identification
- NCT ID
- NCT01668771
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,116 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 10, 2012
- Primary completion
- Not listed
- Completion
- May 12, 2013
- Last update posted
- Apr 4, 2018
2012 – 2013
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Cancer Institute (NCI), 9000 Rockville Pike | Bethesda | Maryland | 20892 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01668771, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 4, 2018 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01668771 live on ClinicalTrials.gov.